The use of complementary medicine for healthy aging

Alternative Therapies in Health and Medicine

Volumn 4, Issue 4, 1998, Pages 42-48

  Bland, Jeffrey S ^a,b  

^a HealthComm International Inc   (United States)

^b Functional Medicine Research Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGING; ALTERNATIVE MEDICINE; HEALTH STATUS; HUMAN; PHYSIOLOGY; REVIEW;

AGING; COMPLEMENTARY THERAPIES; HEALTH STATUS; HUMANS;

EID: 0032112295     PISSN: 10786791     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (72)

1. Olshansky SJ, Carnes BA, Cassel CK. In search of Methuselah: estimating the upper limits to human longevity. Science. 1990;250:634-640.
2. Roush W. Live long and prosper? Science. 1996;273:42-46.
3. Fries JF. Aging, natural death, and the compression of morbidity. N Engl J Med. 1980;303:130.
4. Murray CJL, Lopez AD. Alternative projections of mortality by cause 1990-2020: global burden of disease. Lancet. 1997;349:1493-1504.
5. Bishop JE, Waldholz M. Genome. New York, NY: Simon & Schuster; 1990.
6. Berdanier CD, ed. Nutrients and Gene Expression: Clinical Aspects. Boca Raton, Fla: CRC Press; 1996.
7. Baeurle PA, ed. Inducible Gene Expression Part 1: Environmental Stresses and Nutrients. Boston, Mass: Birkhauser; 1994.
8. Motulsky AG. Nutritional genetic susceptibility to common disease. Am J Clin Nutr. 1992;55:1244S.
9. Catteau A, Douriez E, Beaune P, Poisson N, Bonaiti-Pellie C, Laurent P. Genetic polymorphism of induction of CYT1A1 (EROD) activity. Pharmacogenetics. 1995;5:110-119.
10. Steventon GB, Mitchell SC, Waring RH. Human metabolism of paracetamol (acetaminophen) at different dose levels. Drug Metabol Drug Interact. 1996;12(2):111-117.
11. Ambrosone CB, Freudenheim JL, Graham S, et al. Cigarette smoking, N-acetyltransferase 2 genetic polymorphisms, and breast cancer risk. JAMA. 1996;276:1494-1501.
12. Lin HJ. Smokers and breast cancer - 'chemical individuality' and cancer predisposition. JAMA. 1996;276(18):1511.
13. Evans W, Rosenberg IH. Biomarkers: The 10 Keys to Prolonged Vitality. New York, NY: Fireside; 1991.
14. Rucker R, Tinker D. The role of nutrition in gene expression: a fertile field for the application of molecular biology. J Nutr. 1986;116:177-189.
15. Williams R. The concept of genetotrophic disease. Lancet. 1950;1:287-289.
16. Pauling L, Itano HA, Singer SJ, Wells IC. Sickle cell anemia, a molecular disease. Science. 1949;110:543-543.
17. Perrine SP, Ginder GD, Faller DV, et al. A short-term trial of butyrate to stimulate fetal-globin-gene expression in the B-globin disorders. N Engl J Med. 1993;328:81-86.
18. Charache S, Terrin M, Moore R, et al. Effect of hydroxyurea on the frequency of painful crises in sickle cell anemia. N Engl J Med. 1995;332(20):1317-1322.
19. Pantuck EH, Pantuck CB, Garland WA, et al. Stimulatory effects of brussels sprouts and cabbage on human drug metabolism. Clin Pharmacol Ther. 1979;25:88-95.
20. Nijhoff WA, Grubben MJAL, Nagengast FM, et al. Effects of consumption of Brussels' sprouts on intestinal and lymphocytic glutathione S-transferases in humans. Carcinogenesis. 1995;16(9):2125-2128.
21. Weber A, Jager R, Borner A, et al. Can grapefruit juice influence ethinylestradiol bioavailability? Contraception. 1996;53:41-47.
22. Deutsch D. Fabric of Reality. New York, NY: Penguin Press; 1997.
23. Wallace DC. Mitochondrial DNA in aging and disease. Sci Am. 1997;277:40-47.
24. Blount BC, Mack MM, Ames BN, et al. Folate deficiency causes uracil misincorporation into human DNA and chromosome breakage: implications for cancer and neurological damage. Proc Natl Acad Sci U S A. 1997;94:3290-3295.
25. Johns RJ. Mitochondrial DNA and disease. N Engl J Med. 1995;333:638-644.
26. Richter C. Oxidative damage to mitochondria DNA and its relationship to aging. Int J Biochem Cell Biol. 1995;27:647-653.
27. Harman D. The aging process. Proc Natl Acad Sci U S A. 1981;78:7124-7128.
28. Knecht KJ, Dunn JA, McFarland KF, et al. Effect of diabetes and aging on carboxymethyllysine levels in human urine. Diabetes. 1991;40:190-196.
29. Wolff SP, Jiang ZY, Hunt JV. Protein glycation and oxidative stress in diabetes mellitus and aging. Free Radic Biol Med. 1991;10:339-352.
30. Schmidt AM, Weidman E, Lalla E, et al. Advanced glycation endproducts (AGEs) induce oxidant stress in the gingiva: a potential mechanism underlying accelerated periodontal disease associated with diabetes. J Periodontal Res. 1996;31:508-515.
31. Dyer DG, Dunn JA, Thorpe SR, et al. Accumulation of Maillard reaction products in skin collagen in diabetes and aging. J Clin Invest. 1993;91:2463-2469.
32. Schmidt AM, Hori O, Chen JX, et al. Advanced glycation endproducts interacting with their endothelial receptor induce expression of vascular cell adhesion molecule-1 (VCAM-1) in cultured human endothelial cells and in mice - a potential mechanism for the accelerated vasculopathy of diabetes. J Clin Invest. 1995;96:1395-1402.
33. Tong P, Thomas T, Berrish T, et al. Cell membrane dynamics and insulin resistance in non-insulin-dependent diabetes mellitus. Lancet. 1995;345:357-358.
34. Paolisso G, Giugliano D, Pizza G, et al. Magnesium infusion potentiates glucose-induced insulin secretion in aged patients with impaired glucose tolerance. Diabetes Care. 1992;15(1):1-7.
35. Paolisso G, Sgambuto S, Pizza G, Passariello N, Varricchio M, D'Onofrio F. Improved insulin response and action by chronic magnesium administration in aged NIDDM subjects. Diabetes Care. 1989;12:265-269.
36. Goldfine A, Simonson D, Folli F, Patti ME, Kohn CR. Metabolic effects of sodium metavanadate in humans with insulin-dependent and noninsulin-dependent diabetes mellitus in vivo and in vitro studies. J Clin Endocrinol Metab. 1995;80:3311-3319.
37. Roeback J, Chambless L, Fletcher RH. Effects of chromium supplementation on serum high-density lipoprotein cholesterol levels in men taking beta-blockers. Ann Intern Med. 1991;115:917-924.
38. Ballou SP, Lozanski FB, Hodder S, et al. Quantitative and qualitative alternations of acute-phase proteins in healthy elderly persons. Age Ageing. 1996;9(3)202-212.
39. Gebbers JO, Laissue JA. Immunologic structures and functions of the gut. Schweiz Arch Tierheilkd. 1989;131:221-238.
40. Alican I, Kubes P. A critical role for nitric oxide in intestinal barrier function and dysfunction. Am J Physiol. 1996;270(2, pt 1):g225-g237.
41. Fargeas MJ, Theodorou V, Weirich B, Fioramonti J, Bueno L. Decrease in sensitisation rate and intestinal anaphylactic response after nitric oxide synthase inhibition in a food sensitivity model. Gut. 1996;38:598-602.
42. Hunter JU. Food allergy - or enterometabolic disorder? Lancet. 1991;338:495-495.
43. Kruase A, Kamradt T, Burmester GR. Potential infectious agents in the induction of arthritides. Curr Opin Rheumatol. 1996;8:203-209.
44. Peltonen R, Nenonen M, Helve T, et al. Faecal microbial flora and disease activity in rheumatoid arthritis during a vegan diet. Br J Rheumatol. 1997;36:64-68.
45. Mielants H, DeVos M, Goemaere S, et al. Intestinal mucosal permeability in inflammatory rheumatic diseases. II. Role of disease. J Rheumatol. 1991;18(3):394-400.
46. Bland J, Barrager E, Reedy RG, Bland K. A medical food-supplemented detoxification program in the management of chronic health problems. Altern Ther Health Med. 1995;1(5):62-71.
47. Elmer GW, Surawicz CM, McFarland LV. Biotherapeutic agents - a neglected modality for the treatment and prevention of selected intestinal and vaginal infections. JAMA. 1996;275:870-876.
48. Galvez J. Application of natural products in experimental models of intestinal inflammation in rats.Methods Find Exp Clin Pharmacol. 1996;18(suppl B):7-10.
49. Sreejayan N, Rao MN. Nitric oxide scavenging by curcuminoids. J Pharm Pharmacol. 1997;49:105-107.
50. Ammon HPT, Safayhi H, Mack T, Sabieraj J. Mechanism of antiinflammatory actions of curcumine and boswellic acids. J Ethnopharmacol. 1993;38:113-119.
51. Jonas WB, Rapoza CP, Blair WF. The effects of niacinamide on osteoarthritis: a pilot study. Inflamm Res. 1996;45:330-334.
52. Kaufman W. Macinamide therapy for joint instability: therapeutic reversal of a common clinical manifestation of the normal aging process. Conn Med. 1953;17:584-589.
53. Stewart WF, Kawas C, Corrada M, Metter EJ. Risk of Alzheimer's disease and duration of NSAID use. Neurology. 1997;48:626-632.
54. Ridker PM, Cushman M, Stampfer MJ, Tracy RP, Hennekens CH. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med. 1997;336:973-979.
55. Kalaria RN. Arterioschlerosis, apolipoprotein E, and Alzheimer's disease. Lancet. 1997;349:1174.
56. Latchman DS, Itzhaki RF, Faragher B. Herpes simplex virus and risk of Alzheimer's disease. Lancet. 1997;349:1101-1102.
57. Hofman A, Ott A, Breteler MM, et al. Atherosclerosis, apolipoprotein E, and prevalence of dementia and Alzheimer's disease in the Rotterdam Study. Lancet. 1997;349:151-154.
58. Lehtimaki T, Frankberg-Lakkala H, Solakivi T, et al. The effect of short-term fasting, apoliprotein E gene polymorphism, and sex on plasma lipids. Am J Clin Nutr. 1997;66:599-605.
59. Lindenbaum J, Healton EB, Savage DG, et al. Neuropsychiatrie disorders caused by cobalamin deficiency in the absence of anemia or macrocytosis. N Engl J Med. 1995;318:1720-1728.
60. 6 supplements in elderly people with normal serum vitamin concentrations. Lancet. 1995;346:85-89.
61. Graham IM, Daly LE, Refsum HM, et al. Plasma homocysteine as a risk factor for vascular disease - the European Concerted Action Project. JAMA. 1997;277:1775-1781.
62. McCully KS. The Homocysteine Revolution: Medicine for the New Millennium. New Canaan, Conn: Keats Publishing Inc; 1997.
63. Herbert V, Bigaouette J. Call for endorsement of a petition to the Food and Drug Administration to always add vitamin B-12 to any folate fortification of supplement. Am J Clin Nutr. 1997;65(2):572-573.
64. Blount BC, Mack MM, Wehr CM, et al. Folate deficiency causes uracel misincorporation into human DNA and chromosome breakage: implications for cancer and neuronal damage. Proc Natl Acad Sci U S A. 1997;94:3290-3295.
65. Patel DK, Ogunbona A, Notarianni LJ, et al. Depletion of plasma glycine and effect of glycine by mouth on salicylate metabolism during aspirin overdose. Hum Exp Toxicol. 1990;9:389-395.
66. Mitchell J. Acetaminophen toxicity. N Engl J Med. 1988;319(24):1601-1602.
67. Yu R, Jiao JJ, Duh JL, Gudehithluk, Tan TH, Kong AN. Activation of nitrogen-activated protein kinases by green tea polyphenols: potential signaling pathways in the regulation of antioxidant-responsive element-mediated phase II enzyme gene expressions. Carcinogenesis. 1997;18(2):451-456.
68. Mariotti S, Sansoni P, Barbesino G, et al. Thyroid and other organ-specific autoantibodies in healthy centenarians. Lancet. 1992;339:1506-1508.
69. Meydani M, Natiello F, Goldin B, et al. Effect of long-term fish oil supplementation on vitamin E status and lipid peroxidation in women. J Nutr. 1991;121:484-91.
70. Blumberg JB. Interactions between vitamin E, free radicals, and immunity during the aging process. Adv Exp Med Biol. 1994;366:325-333.
71. Pert CB. Molecules of Emotion - Why You Feel the Way You Feel. New York, NY: Simon & Schuster; 1997.
72. Evans W. Exercise, nutrition and aging. J Nutr. 1992;122:796-801.